How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | DLBDolby Laboratories, Inc. | SSentinelOne, Inc. | PATHUiPath, Inc. | QLYSQUALYS, INC. | Median of the restexcluding DLB |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $62.31▲ 1.25 (2.05%) | $22.50▼ 0.27 (1.19%) | $13.71▲ 0.28 (2.08%) | $208.20▲ 11.50 (5.85%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 7.3/10 | 4.7/10 | 8.7/10 | 8.7/10 | 8.7/10 |
| Market value | $5.97B | $7.43B | $7.38B | $7.44B | |
| Revenue | $1.35B | $1.00B | $1.61B | $669.1M | |
| Profit | $255.0M | -$450.7M | $282.3M | $198.3M | |
| Revenue growthChange in sales versus the prior year. | 5.9% | 21.9% | 12.7% | 10.1% | 12.7% |
| Gross marginShare of sales left after the direct cost of producing them. | 88.1% | 74.1% | 83.2% | 82.8% | 82.8% |
| Operating marginShare of sales left after running the business, before interest and tax. | 19.6% | -32.1% | 3.5% | 33.2% | 3.5% |
| Profit marginProfit kept from each dollar of sales. | 18.9% | -45.0% | 17.5% | 29.6% | 17.5% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 32.3% | 7.6% | 21.9% | 45.5% | 21.9% |
| Return on equityProfit against the owners' stake in the company. | 9.7% | -31.4% | 13.6% | 35.3% | 13.6% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 11.6% | -20.0% | 3.7% | 57.4% | 3.7% |
| P/E ratioPrice paid per dollar of annual profit. | 23.42x | — | 26.13x | 37.51x | 31.82x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | — | — | — |
| Price to book | 2.28x | 5.17x | 3.54x | 13.26x | 5.17x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.23x | 0.70x | 0.53x | 0.95x | 0.70x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/8 | 3/8 | 7/8 | 7/8 | 7.0 |
| Bankruptcy riskAltman Z-Score zone. | n/a for banks | distress | safe | safe |
How DLB compares with the others
- DLB's operating margin of 19.6% is higher than the median of the other companies selected (3.5%).
- Its revenue grew more slowly than the median of the other companies selected: 5.9% against 12.7%.
- It trades at a lower P/E than the median of the other companies selected: 23.4x against 31.8x.
- Its liabilities are lower relative to equity than the median of the other companies selected: 0.2x against 0.7x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.